London & Capital Asset Management Ltd
Source: SEC Form 13F · as of Mar 2026London & Capital Asset Management Ltd holds 14 biotech & pharma companies tracked by BioSniper, totaling $345.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$345.5M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 880,594 | $238.2M |
| GEHCGE HealthCare Technologies Inc. | 925,284 | $65.8M |
| ZTSZoetis Inc. | 276,759 | $32.7M |
| JNJJOHNSON & JOHNSON | 11,586 | $2.8M |
| MRKMerck & Co., Inc. | 11,289 | $1.4M |
| ABBVAbbVie Inc. | 5,196 | $1.1M |
| ABTABBOTT LABORATORIES | 7,257 | $744K |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 10,700 | $671K |
| PMPhilip Morris International Inc | 2,945 | $487K |
| LLYELI LILLY & Co | 393 | $362K |
| CORCencora Inc. | 1,100 | $346K |
| GILDGILEAD SCIENCES, INC. | 2,008 | $280K |
| PFEPFIZER INC | 9,685 | $272K |
| AMGNAMGEN INC | 717 | $252K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.